24 February 2021

GSK Stockmann advises Wilhelm von Finck Group on participation in AVIAM

GSK Stockmann has comprehensively advised the Wilhelm von Finck Group (PE & Development) on the acquisition of 20% of the limited partnership shares in the project developer AVIAM, which specialises in care homes and residential real estate. The parties agreed to keep the purchase price confidential.

AVIAM Projektentwicklung AG & Co KGaA, based in Grünwald near Munich, arose out of the Bavarian residential developer Luxury M in 2019. Since then, the company’s deal volume has increased to approximately EUR 150 million. With the involvement of the Wilhelm von Finck Group as a strategic long-term investor from the region, it is planned to realise sustainable and, specifically, large-volume projects with a project volume of more than 100 million euros in the two business areas of care homes and residential real estate. This is intended to further expand the portfolio, which is currently still predominantly located in southern Germany.

Günter Koller, former founding partner of GSK Stockmann and managing director of the Wilhelm Finck Group, was appointed to AVIAM’s supervisory board.

GSK Stockmann provided comprehensive legal advice to the Wilhelm von Finck Group on the participation, in particular on the share purchase agreement and the joint venture agreement.

Dirk Brückner, who has been supporting the company for many years and most recently also advised on the further development of former Karstadt Sport in Neuhauser Straße in Munich, was the lead partner.

Advisers of Wilhelm von Finck Group:

GSK Stockmann: Dirk Brückner (lead, Real Estate); Marcel Vietor (Corporate), Dirk Koch (Tax); Associates: Katharina Feierabend (Real Estate), Yannik Stahl (Corporate), Stephan Wachsmuth (Tax), Martin Sturm (Public Law)

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 24 June 2022

    GSK Update: Accelerated construction of LNG terminals in Germany

    Read more
  • 06 May 2022

    GSK Update: Whistleblowing 2.0: What will the second draft of the Whistleblower Protection Act bring along?

    Read more
  • 25 April 2022

    GSK Update: Ban on public contracts with Russian companies

    Read more
Contact person

Dr. Dirk Brückner

Partner*

+49 89 288174-0

dirk.brueckner@gsk.de

* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral